Safety analysis of immediate breast reconstruction with a deep inferior epigastric perforator (DIEP) flap in the post-COVID-19 era: a comparison between pre- and post-pandemic cohorts
Open Access
- 1 November 2023
- journal article
- research article
- Published by AME Publishing Company in Gland Surgery
- Vol. 12 (11) , 1475-1484
Abstract
Background: The demand for immediate breast reconstruction with a deep inferior epigastric perforator (DIEP) flap is recovering as coronavirus disease 2019 (COVID-19) transitions from a pandemic to an endemic. This study sought to evaluate the safety of resuming DIEP flap reconstruction in the post-COVID-19 era. Methods: Consecutive breast cancer patients who underwent immediate breast reconstruction with a DIEP flap at the Comprehensive Breast Health Center, Ruijin Hospital were retrospectively included in the study. The patients were divided into a post-pandemic group (Group A) and a pre-pandemic group (Group B). The clinicopathological factors, surgical procedures, and rates of post-operative complications were compared between the two groups using the Mann-Whitney U test and Chi-squared test. Results: A total of 167 patients were included in the study, of whom 119 (71.3%) were in Group A and 48 (28.7%) were in Group B. The two groups had similar clinicopathological features, including age (P=0.988), body mass index (P=0.504), and tumor, node, metastasis (TNM) stage (P=0.932). The Group A patients were more likely to receive single perforator DIEP flap transplantation than the Group B patients (n=28, 22.8% vs. n=3, 5.8%, P=0.007). There was a numerical decrease in the mean operating time of Group A patients compared to Group B patients (9.82 vs. 10.12 hours, P=0.172). The mean length of stay after the surgery was significantly shorter after the pandemic than before the pandemic (11.2 vs. 14.3 days, PConclusions: This study provides evidence that resuming DIEP reconstruction is safe in the post-COVID-19 era.Keywords
This publication has 26 references indexed in Scilit:
- Treatment protocol to allow reconstructive breast surgery during COVID-19 pandemic2020
- Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusAnnals of Oncology, 2020
- The American College of Surgeons Responds to COVID-19Journal of the American College of Surgeons, 2020
- Slowing the Spread and Minimizing the Impact of COVID-19: Lessons from the Past and Recommendations for the Plastic SurgeonPlastic and Reconstructive Surgery, 2020
- Management of early breast cancer during the COVID-19 pandemic in BrazilBreast Cancer Research and Treatment, 2020
- Patient-reported treatment delays in breast cancer care during the COVID-19 pandemicBreast Cancer Research and Treatment, 2020
- Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemicThe Breast, 2020
- Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)The Breast, 2020
- ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast CancerESMO Open, 2020
- Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortiumBreast Cancer Research and Treatment, 2020